Product Description

GW Pharmaceuticals is biopharmaceutical company, founded in the UK in 1998 . It has been listed on the NASDAQ Stock Market since May 2013. The company has operations in both the US and the UK. GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain. It is the first and only company to get FDA approval for a Cannabidiol-based drug.


PARAMETERS Trading Specifications per Account Type
PREMIUM ZERO MICRO AUTO
Typical Spread in quote currency per unit 0.85 0.85 0.85 0.85
Size of 1 lot 100 shares 100 shares 100 shares 100 shares
Minimum Contract size, lots 0.01 0.01 0.01 0.01
Maximum Contract size, lots 50.0 50.0 50.0 50.0
Tick value per 1 lot 1 USD 1 USD 1 USD 1 USD
Volume limitation 50 lots per account 50 lots per account 50 lots per account 50 lots per account
Margin requirement 7% 7% 7% 7%
Minimum Price Increment 0.01 0.01 0.01 0.01
Limit and Stop Levels 10.0 10.0 10.0 10.0
Margin Call / Stop out Level 50 % / 20% 50 % / 20% 40% / 10% 50 % / 20%
Negative balance protection Yes Yes Yes Yes
Swap free days allowance 0 0 0 0
products